Rezaee-Zavareh Mohammad Saeid, Kim Naomy, Yeo Yee Hui, Kim Hyunseok, Lee Jeong Min, Sirlin Claude B, Taouli Bachir, Saouaf Rola, Wachsman Ashley M, Noureddin Mazen, Wang Zhiping, Moore Jason, Li Debiao, Singal Amit G, Yang Ju Dong
Middle East Liver Diseases Center, Tehran, Iran.
Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Front Oncol. 2024 Feb 28;14:1355454. doi: 10.3389/fonc.2024.1355454. eCollection 2024.
BACKGROUND AND AIMS: With the rapid growth of artificial intelligence (AI) applications in various fields, understanding its impact on liver cancer research is paramount. This scientometrics project aims to investigate publication trends and topics in AI-related publications in liver cancer. MATERIALS AND METHODS: We employed a search strategy to identify AI-related publications in liver cancer using Scopus database. We analyzed the number of publications, author affiliations, and journals that publish AI-related publications in liver cancer. Finally, the publications were grouped based on intended application. RESULTS: We identified 3950 eligible publications (2695 articles, 366 reviews, and 889 other document types) from 1968 to August 3, 2023. There was a 12.7-fold increase in AI-related publications from 2013 to 2022. By comparison, the number of total publications on liver cancer increased by 1.7-fold. Our analysis revealed a significant shift in trends of AI-related publications on liver cancer in 2019. We also found a statistically significant consistent increase in numbers of AI-related publications over time (tau = 0.756, p < 0.0001). Eight (53%) of the top 15 journals with the most publications were radiology journals. The largest number of publications were from China (n=1156), the US (n=719), and Germany (n=236). The three most common publication categories were "medical image analysis for diagnosis" (37%), "diagnostic or prognostic biomarkers modeling & bioinformatics" (19%), and "genomic or molecular analysis" (18%). CONCLUSION: Our study reveals increasing interest in AI for liver cancer research, evidenced by a 12.7-fold growth in related publications over the past decade. A common application of AI is in medical imaging analysis for various purposes. China, the US, and Germany are leading contributors.
背景与目的:随着人工智能(AI)在各个领域的迅速发展,了解其对肝癌研究的影响至关重要。本科学计量学项目旨在调查肝癌领域与AI相关出版物的发表趋势和主题。 材料与方法:我们采用检索策略,利用Scopus数据库识别肝癌领域与AI相关的出版物。我们分析了出版物数量、作者单位以及发表肝癌领域与AI相关出版物的期刊。最后,根据预期应用对出版物进行分组。 结果:我们从1968年至2023年8月3日共识别出3950篇符合条件的出版物(2695篇文章、366篇综述和889篇其他文献类型)。2013年至2022年,与AI相关的出版物数量增长了12.7倍。相比之下,肝癌领域的总出版物数量增长了1.7倍。我们的分析显示,2019年肝癌领域与AI相关出版物的趋势发生了显著变化。我们还发现,随着时间的推移,与AI相关的出版物数量在统计学上呈显著持续增长(tau = 0.756,p < 0.0001)。发表量排名前15的期刊中有8种(53%)是放射学期刊。出版物数量最多的国家是中国(n = 1156)、美国(n = 719)和德国(n = 236)。三个最常见的出版类别是“用于诊断的医学图像分析”(37%)、“诊断或预后生物标志物建模与生物信息学”(19%)和“基因组或分子分析”(18%)。 结论:我们的研究表明,过去十年中相关出版物增长了12.7倍,这证明了对AI在肝癌研究中的兴趣日益浓厚。AI的一个常见应用是用于各种目的的医学影像分析。中国、美国和德国是主要贡献国。
Front Biosci (Landmark Ed). 2022-8-31
J Med Internet Res. 2022-11-30
Int J Environ Res Public Health. 2022-12-22
Front Med (Lausanne). 2022-11-2
Patterns (N Y). 2023-9-8
Multimed Tools Appl. 2023-3-2
Ann Transl Med. 2022-12
Diagnostics (Basel). 2022-12-9
J Hepatol. 2022-12
Future Sci OA. 2022-2-10